Download PDF
1 / Pages

Other users also viewed these articles

Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors M. Serino; C. Freitas; M. Martins; P. Ferreira; C. Cardoso; F. Veiga; V. Santos; D. Araújo; H. Novais-Bastos; A. Magalhães; H. Queiroga; G. Fernandes; V. Hespanhol;
Pulmonol. 2024;30:352-61
Endotypes in bronchiectasis: moving towards precision medicine. A narrative review M. Martins; H.R. Keir; J.D. Chalmers;
Pulmonol. 2023;29:505-17
The benefit of macrolide therapy in patients with pneumococcal pneumonia is only present in patients with bacteremia J. Gonçalves-Pereira; L. Costa; I. Silva; A. Simões; F. Froes; P. Mergulhão; P. Varela Ramos; D. Leal; R. Alves; M. Custódio; A. Gomes;
Pulmonol. 2023;29:253-6